Medication info
Elpas Tablets (L-Carnitine)

Elpas Tablets (L-Carnitine)

OTC medicationTabletOral
Ingredient · strength
L-Carnitine›330mg / 1 tablet
Manufacturer / importer
Ilhwa Co., Ltd.
Appearance
White round film-coated tablets
Packaging
90 tablets/box [(10 tablets/PTP*9)]
Approval status
Active

MFDS item code 202204012 · Notified 2022.11.04

Summary

Main use
Treatment of carnitine deficiency and myocardial metabolic disorders due to ischemic heart disease
Who takes it
Adults
Adult dose
Adults: Administer (take) 2-3g of L-carnitine orally in 2-3 divided doses daily. Adjust the dose as appropriate according to age and symptoms.

Ingredients

Manufacturer
Ilhwa Co., Ltd.

Efficacy & effects

Treatment of carnitine deficiency and myocardial metabolic disorders due to ischemic heart disease

  • Primary carnitine deficiency
  • secondary carnitine deficiency
  • angina
  • acute myocardial infarction
View approved original text

This medication is used for primary and secondary carnitine deficiency and myocardial metabolic disorders caused by ischemic heart disease, such as angina and acute myocardial infarction.

How to take

Adult dose

Adults: Administer (take) 2-3g of L-carnitine orally in 2-3 divided doses daily. Adjust the dose as appropriate according to age and symptoms.

Precautions

This medication should not be used in patients who have allergic reactions to it. During use, temporary symptoms such as nausea, vomiting, abdominal pain, diarrhea, and body odor may occur. Additionally, there have been reports of skin rash or hives, and facial swelling, so if these symptoms appear, immediate consultation with a healthcare professional is necessary. Patients with impaired kidney function may experience mild muscle weakness, so caution is needed. Pregnant women or women who may become pregnant should only take this medication when the benefits of treatment outweigh the risks, as its safety has not been fully confirmed. Furthermore, it is unclear how much of this medication is transmitted through breast milk, but many drugs can be passed to the baby through breast milk, so it should be used with caution while breastfeeding.

Side effects

  • Transient area
  • vomiting
  • abdominal pain
  • diarrhea
  • body odor
  • rash
  • urticaria
  • facial edema
  • myasthenia

Not everyone experiences these, and they can vary from person to person.

Interactions

Drug interactions

This medication should be used in consultation with a doctor or pharmacist when administered with other injectable lipid preparations.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture from entering. It is advisable to maintain the storage temperature between 1 and 30 degrees Celsius at room temperature. Proper storage will help maintain the medication’s effectiveness and safety.

Appearance and packaging

Appearance

White round film-coated tablets

Package unit

90 tablets/box [(10 tablets/PTP*9)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

  • QIn what situations is this medication taken?

    This medication is used for primary and secondary carnitine deficiency and metabolic disorders of the heart due to ischemic heart disease (angina, acute myocardial infarction). The dosage should be adjusted according to age and symptoms, so please consult with your doctor or pharmacist regarding whether and how much to take.

    Answers 1 · 2026.09.14

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.